Last reviewed · How we verify
Anti-scorpion venom serum Birmex
Anti-scorpion venom serum Birmex is a Antivenom (polyclonal antiserum) Biologic drug developed by Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.. It is currently in Phase 3 development for Scorpion envenomation (treatment of systemic toxicity from scorpion stings). Also known as: anti-scorpion venom serum.
Anti-scorpion venom serum provides passive immunization by supplying antibodies that neutralize scorpion venom toxins.
Anti-scorpion venom serum provides passive immunization by supplying antibodies that neutralize scorpion venom toxins. Used for Scorpion envenomation (treatment of systemic toxicity from scorpion stings).
At a glance
| Generic name | Anti-scorpion venom serum Birmex |
|---|---|
| Also known as | anti-scorpion venom serum |
| Sponsor | Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. |
| Drug class | Antivenom (polyclonal antiserum) |
| Target | Scorpion venom toxins (multiple components including neurotoxins) |
| Modality | Biologic |
| Therapeutic area | Toxicology / Emergency Medicine |
| Phase | Phase 3 |
Mechanism of action
This is a polyclonal antiserum derived from immunized animals (typically horses or sheep) that contain antibodies against scorpion venom components. When administered to envenomated patients, these antibodies bind to and neutralize venom toxins, preventing their pathological effects on the nervous and cardiovascular systems. The serum provides immediate but temporary protection, with antibodies gradually cleared over days to weeks.
Approved indications
- Scorpion envenomation (treatment of systemic toxicity from scorpion stings)
Common side effects
- Serum sickness
- Hypersensitivity reactions
- Anaphylaxis
Key clinical trials
- Decrease in Temperature as a Pagtonomic Sign by Scorpion Sting
- Randomized Controlled Trial to Compare Two Anti-scorpion Serums (PHASE4)
- Compare Two Anti-Scorpion Venom Serum In Children (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-scorpion venom serum Birmex CI brief — competitive landscape report
- Anti-scorpion venom serum Birmex updates RSS · CI watch RSS
- Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. portfolio CI
Frequently asked questions about Anti-scorpion venom serum Birmex
What is Anti-scorpion venom serum Birmex?
How does Anti-scorpion venom serum Birmex work?
What is Anti-scorpion venom serum Birmex used for?
Who makes Anti-scorpion venom serum Birmex?
Is Anti-scorpion venom serum Birmex also known as anything else?
What drug class is Anti-scorpion venom serum Birmex in?
What development phase is Anti-scorpion venom serum Birmex in?
What are the side effects of Anti-scorpion venom serum Birmex?
What does Anti-scorpion venom serum Birmex target?
Related
- Drug class: All Antivenom (polyclonal antiserum) drugs
- Target: All drugs targeting Scorpion venom toxins (multiple components including neurotoxins)
- Manufacturer: Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. — full pipeline
- Therapeutic area: All drugs in Toxicology / Emergency Medicine
- Indication: Drugs for Scorpion envenomation (treatment of systemic toxicity from scorpion stings)
- Also known as: anti-scorpion venom serum
- Compare: Anti-scorpion venom serum Birmex vs similar drugs
- Pricing: Anti-scorpion venom serum Birmex cost, discount & access